IQ-AI Interim Loss Widens As Covid-19 Delays Other Medical Treatments
IQ-AI Interim Loss Widens As Covid-19 Delays Other Medical Treatments
Read moreWed, 26th Jun 2019 10:49
IQ-AI Interim Loss Widens As Covid-19 Delays Other Medical Treatments
Read moreUK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination
Read moreIN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track
Read moreIN BRIEF: IQ-AI Starts Development Of Cancer Detection Product
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks
Read moreIQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth
Read moreIQ-AI Secures StoneChecker Software Approval In South Korea
Read moreIQ-AI Signs Distribution Agreement For Liver Analysis Technology
Read more(Sharecast News) - IQ-AI announced on Thursday that its subsidiary Imaging Biometrics (IB) has entered into a global distribution agreement with AI Metrics.
Read moreIQ-AI To Seek Buyer For Stonechecker Software Following Review
Read moreIQ-AI Excited By New Technology, Will Form "Backbone" Of New Products
Read moreUPDATE: Feedback Shares Rise On IQ-AI US FDA Marketing Clearance
Read moreIQ-AI Shares Higher On US FDA Marketing Clearance For StoneChecker
Read more(Alliance News) - Medical software services provider IQ-AI Ltd on Monday said it narrowed its losses on a sharp revenue rise during the first half of 2019.In the six months to June 30, the
Read more